BPI Signs GE Healthcare As Premier Sponsor of the 2016 BioProcess International Awards

Share Article

BioProcess International magazine is pleased to announce that GE Healthcare Life Sciences has signed on as a premier sponsor of the 2016 BioProcess International Awards, recognizing excellence in the people, organizations and technology applications in bioprocessing. Nominations for the awards are open until June 30, 2016.

News Image
We are proud to be at the forefront of the industry's transformation of nature's phenomena into life changing high quality biopharmaceuticals.

BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces an agreement with GE Healthcare Life Sciences to become a premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the People, Organizations and Technology Applications in Bioprocessing.

The BPI Awards has been developed to encourage the leaders, scientists, manufacturers, and suppliers to raise the awareness of their individual achievements, collaborations, successful business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base.

“The 2016 BPI Award program honors the innovative companies and individuals that are driving the biopharmaceutical industry forward,” said Brian Caine, BioProcess International’s Co-Founder and Publisher. “GE Healthcare Biologics has consistently been on the forefront of innovation and new technology creation for many many years. We welcome them as a premier sponsor of the 2016 BioProcess International Awards.”

“Supporting our customers as they rapidly make new exciting treatments an everyday reality is an honor”, said Jan Makela, VP Bioprocessing, GE Healthcare’s Life Sciences business. “We are proud to be at the forefront of the industry’s transformation of nature’s phenomena into life changing high quality biopharmaceuticals.”

The nominations deadline is June 30, 2016. To submit your nomination visit http://www.bioprocessintl.com/awards.

Awards will be granted recognizing achievements within the following categories:

The People:

  •     Best Collaboration
  •     Excellence in Leadership

The Organizations:

  •     Excellence in Facility Design or Retrofit
  •     Emerging Company
  •     Corporate Citizenship

The Technologies:

  •     Best Technology Application - Upstream (user or supplier)
  •     Best Technology Application - Downstream (user or supplier)
  •     Best Technology Application - Analytical (user or supplier)

About GE Healthcare Life Sciences
GE Healthcare's Life Sciences business provides a wide range of bioprocessing products and services that enable the development and manufacture of high-quality biotherapeutics and vaccines. Using our knowledge and expertise, we support our customers in increasing speed to market, while avoiding unnecessary costs and improving quality and performance in drug manufacturing. As a provider of high-quality products, customized technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.

About BioProcess International
BioProcess International is part of the T&F Informa Knowledge and Networking Group, the leading provider of scientific, technological, and business information to the global life science community.

To submit a nomination or request sponsorship information, please visit: http://www.bioprocessintl.com/awards

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Leah Rosin
Follow >
Visit website